Lucile Mollet
5Patents
1h-index
3Co-inventors
40Inventor score
Filing activity: Feb 4, 2010 → Oct 5, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9012214B2 | Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions | Emerging Cross-Sectional Technologies | 7 | Active |
| US9914937B2 | Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US10519466B2 | Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US10793877B2 | Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US12163150B2 | Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.